These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34483917)

  • 1. Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support.
    Zylbersztajn B; Parker S; Navea D; Izquierdo G; Ortiz P; Torres JP; Fajardo C; Diaz R; Valverde C; Roberts J
    Front Pharmacol; 2021; 12():709332. PubMed ID: 34483917
    [No Abstract]   [Full Text] [Related]  

  • 2. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
    Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE
    Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem Disposition in Neonatal and Pediatric Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.
    Pokorná P; Michaličková D; Tibboel D; Berner J
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients.
    Alsultan A; Aldawsari MR; Alturaiq NK; Syed SA; Alsubai A; Kurdee Z; Alsubaie S; Alqahtani S; Abouelkheir M
    Pediatr Neonatol; 2024 Jan; ():. PubMed ID: 38218717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Modeling Using Real-World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement-Clinical Outcomes Relationship.
    Salem AM; Smith T; Wilkes J; Bailly DK; Heyrend C; Profsky M; Yellepeddi VK; Gopalakrishnan M
    J Clin Pharmacol; 2024 Jan; 64(1):30-44. PubMed ID: 37565528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
    Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
    Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients.
    Polášková L; Murínová I; Gregorová J; Slanař O; Šíma M
    Front Pharmacol; 2024; 15():1364681. PubMed ID: 38895623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment.
    Ahmed KA; Ibrahim A; Gonzalez D; Nur AO
    Drug Des Devel Ther; 2024; 18():81-95. PubMed ID: 38260090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?
    Sette C; Mariani M; Grasselli L; Mesini A; Saffioti C; Russo C; Bandettini R; Moscatelli A; Ramenghi LA; Castagnola E
    Antibiotics (Basel); 2023 Oct; 12(11):. PubMed ID: 37998768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone Pharmacokinetics and Pharmacodynamic Target Attainment for Three Pediatric Patients Receiving Continuous Kidney Replacement Therapy.
    Hambrick HR; Cervantes F; Dong M; Tang P; Arbough T; Vinks AA; Mizuno T; Goldstein SL; Kaplan J; Girdwood ST
    J Pediatr Pharmacol Ther; 2024 Apr; 29(2):180-187. PubMed ID: 38596427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing Hemodialysis.
    Oda K; Jono H; Saito H
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0008923. PubMed ID: 37195225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects.
    Huang Z; Yang X; Jin Y; Yu J; Cao G; Wang J; Hu Y; Dai J; Wu J; Wei Q; Tian Y; Yu S; Zhu X; Mao X; Liu W; Liang H; Zheng S; Ju Y; Wang Z; Zhang J; Wu X
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0133023. PubMed ID: 38054726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Therapeutic Target Attainment of Meropenem in Pediatric Post-Liver Transplant Patients: Extended vs Intermittent Infusion.
    Morales Junior R; Juodinis VD; Telles JP; Romano P; Duarte NJC; De Souza DC; Santos SRCJ
    Transplant Proc; 2023 Dec; 55(10):2456-2461. PubMed ID: 37923571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management.
    Bae SH; Yim DS; Lee H; Park AR; Kwon JE; Sumiko H; Han S
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31075931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of C-reactive protein dynamics during meropenem treatment in neonates and infants.
    Soeorg H; Padari H; Ilmoja ML; Herodes K; Kipper K; Lutsar I; Metsvaht T;
    Br J Clin Pharmacol; 2024 Mar; 90(3):801-811. PubMed ID: 37903648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model.
    Polášková L; Hartinger JM; Murínová I; Michálek P; Slanař O; Šíma M
    J Chemother; 2024 Jun; ():1-9. PubMed ID: 38887026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-informed precision dosing in vancomycin treatment.
    Yoon S; Guk J; Lee SG; Chae D; Kim JH; Park K
    Front Pharmacol; 2023; 14():1252757. PubMed ID: 37876732
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic-Pharmacodynamic Modeling of Midazolam in Pediatric Surgery.
    Flores-Pérez C; Moreno-Rocha LA; Chávez-Pacheco JL; Noguez-Méndez NA; Flores-Pérez J; Ortiz-Marmolejo D; Sarmiento-Argüello LA
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population.
    Watson E; Khandelwal A; Freijer J; van den Anker J; Lefeber C; Eerdekens M
    J Pain Res; 2019; 12():2835-2850. PubMed ID: 31686902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of antibacterial agents in the older population: a literature review.
    Liu HX; Tang BH; van den Anker J; Hao GX; Zhao W; Zheng Y
    Expert Rev Clin Pharmacol; 2024 Jan; 17(1):19-31. PubMed ID: 38131668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.